Statistics

Total Visits

Views
Concurrent upregulation of BCL-XL and BCL2A1 induces ~1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. 511

Total Visits per Month

November 2014 December 2014 January 2015 February 2015 March 2015 April 2015 May 2015
Concurrent upregulation of BCL-XL and BCL2A1 induces ~1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. 63 54 56 58 16 42 40

File Downloads

Views
4403[1].pdf 144

Top Country Views

Views
United States 263
Russia 85
Poland 46
Denmark 26
Canada 16
China 15
United Kingdom 9
Germany 8
France 3
Hong Kong 3

Top City Views

Views
Minneapolis 106
Spartanburg 64
Houston 31
Miami Beach 16
Toronto 14
Zhengzhou 6
Beijing 5
San Jose 5
Brighton 4
Kansas City 3